Osteoporosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women who have gone through menopause and are between 50 and 65 years old
- People whose bone density scan results fall in a range that suggests lower than normal bone density but not yet full osteoporosis (a T-score between -1 and -3)
- People who have not had any broken bones caused by weak or fragile bones in the past
Who may not be able to join:
- People who do not have parathyroid glands, which are small glands that help the body control calcium and phosphorus levels (confirm with trial site)
- People who have or have had kidney stones
- People who are currently taking medications that can affect bone health, such as corticosteroids, menopausal hormone therapy, anti-oestrogen treatments, or those with an uncontrolled thyroid condition or a thyroid that is either overactive or underactive
- People who have a bone disease such as Paget's disease or osteomalacia (a condition where bones soften due to vitamin D or mineral problems)
- People with chronic alcohol dependency
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Adamah AMOUZOUGAN, MD, Centre Hospitalier Universitaire de Saint Etienne
Phone: (0)477120595
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in bone loss at lumbar site
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.